Abstract:Myopia, a highly prevalent refractive error worldwide, has become an important public health challenge. Recent advances in genomics have clarified the genetic basis of myopia, providing new insights into its pathogenesis. Meanwhile, artificial intelligence(AI), particularly machine learning, has been increasingly applied to medical image analysis and disease prediction, greatly improving the diagnostic accuracy and prognostic assessment of myopia. This review focuses on the application of genomics and AI in the precision diagnosis and treatment of myopia, systematically summarizing the genetic mechanisms, multi-omics data integration,the potential of gene-editing, and machine learning-based predictive modeling. It also discusses the clinical translation of these technologies and the challenges faced, aiming to provide a theoretical basis and practical pathways for individualized myopia prevention and treatment, thereby advancing myopia management into a new era of precision medicine.